Literature DB >> 19962776

Involvement of the cholinergic pathway in glucocorticoid-induced hyperinsulinemia in rats.

Nágela Angelini1, Alex Rafacho, Antonio Carlos Boschero, José Roberto Bosqueiro.   

Abstract

AIMS: We investigated the contribution of the cholinergic nervous system to dexamethasone-induced insulin resistance and hyperinsulinemia in rats.
METHODS: Seventy-day-old Wistar male rats were distributed in groups: control (CTL), vagotomized (VAG), and sham operated (SHAM). On the 90th day of life, half of the rats were treated daily with 1mg/kg of dexamethasone for 5 days (CTL DEX, VAG DEX, and SHAM DEX).
RESULTS: In the presence of 8.3mM glucose plus 100microM carbachol (Cch), isolated islets from CTL DEX secreted significantly more insulin than CTL. Cch-enhancement of secretion was further increased in islets from VAG CTL and VAG DEX than SHAM CTL and SHAM DEX, respectively. In CTL DEX islets, M3R and PLCbeta1 and phosphorylated PKCalpha, but not PKCalpha, protein content was significantly higher compared with each respective control. In islets from VAG DEX, the expression of M3R protein increased significantly compared to VAG CTL and SHAM DEX. Vagotomy per se did not affect insulin resistance, but attenuated fasted and fed insulinemia in VAG DEX, compared with SHAM DEX rats.
CONCLUSION: These data indicate an important participation of the cholinergic nervous system through muscaric receptors in dexamethasone-induced hyperinsulinemia in rats. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962776     DOI: 10.1016/j.diabres.2009.11.008

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  9 in total

1.  Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction.

Authors:  Doaa A Ghareeb; Hani S Hafez; Hend M Hussien; Nihal F Kabapy
Journal:  Metab Brain Dis       Date:  2011-09-01       Impact factor: 3.584

2.  Long-term dexamethasone treatment alters the histomorphology of acinar cells in rat parotid and submandibular glands.

Authors:  Bruna B Bighetti; Gerson F d Assis; Danilo C Vieira; Natalia M Violato; Tania M Cestari; Rumio Taga; José R Bosqueiro; Alex Rafacho
Journal:  Int J Exp Pathol       Date:  2014-09-03       Impact factor: 1.925

3.  Glibenclamide treatment blocks metabolic dysfunctions and improves vagal activity in monosodium glutamate-obese male rats.

Authors:  Claudinéia C S Franco; Kelly V Prates; Carina Previate; Ana M P Moraes; Camila C I Matiusso; Rosiane A Miranda; Júlio C de Oliveira; Laize P Tófolo; Isabela P Martins; Luiz F Barella; Tatiane A Ribeiro; Ananda Malta; Audrei Pavanello; Flávio A Francisco; Rodrigo M Gomes; Vander S Alves; Veridiana M Moreira; Késia P Rigo; Douglas L Almeida; Juliane R de Sant Anna; Marialba A A C Prado; Paulo C F Mathias
Journal:  Endocrine       Date:  2017-02-23       Impact factor: 3.633

4.  Impact of Fish Oil Supplementation and Interruption of Fructose Ingestion on Glucose and Lipid Homeostasis of Rats Drinking Different Concentrations of Fructose.

Authors:  Paola M Sulis; Katia Motta; Amanda M Barbosa; Matheus H Besen; Julia S da Silva; Everson A Nunes; Alex Rafacho
Journal:  Biomed Res Int       Date:  2017-08-08       Impact factor: 3.411

5.  Prevention of Elevation in Plasma Triacylglycerol with High-Dose Bezafibrate Treatment Abolishes Insulin Resistance and Attenuates Glucose Intolerance Induced by Short-Term Treatment with Dexamethasone in Rats.

Authors:  Maiara Destro Inácio; Alex Rafacho; Nathália Aparecida de Paula Camaforte; Poliana Teixeira; Priscilla Maria Ponce Vareda; Natália Moretti Violato; José Roberto Bosqueiro
Journal:  Int J Endocrinol       Date:  2018-11-08       Impact factor: 3.257

Review 6.  Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation.

Authors:  So Yeong Cheon; Juhyun Song
Journal:  Cell Biosci       Date:  2022-06-28       Impact factor: 9.584

7.  Identification of glucocorticoid receptors as potential modulators of parasympathetic and sympathetic neurons within rat intracardiac ganglia.

Authors:  Shaaban A Mousa; Lukas Dehe; Noureddin Aboryag; Mohammed Shaqura; Antje Beyer; Michael Schäfer; Sascha Treskatsch
Journal:  Front Neuroanat       Date:  2022-09-23       Impact factor: 3.543

Review 8.  Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence.

Authors:  Aoibhe M Pasieka; Alex Rafacho
Journal:  Metabolites       Date:  2016-08-03

9.  Glucose Homeostasis Is Not Affected in a Murine Model of Parkinson's Disease Induced by 6-OHDA.

Authors:  Felipe Azevedo Gomes; Rafael Appel Flores; Maciel Alencar Bruxel; Flávia Natividade da Silva; Eduardo Luiz Gasnhar Moreira; Daniel Breseghello Zoccal; Rui Daniel Prediger; Alex Rafacho
Journal:  Front Neurosci       Date:  2019-01-09       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.